Table 3.
Variable | Value |
---|---|
Total interventions | 1,572 |
Interventions per patient, mean (SD) | 8 (9) |
Interventions per patient-day, mean | 1 |
Intervention types, No. (%)a | |
Regimen simplification | 250 (15.9) |
Timing and dosing adjustments | 242 (15.4) |
Antimicrobials and COVID-19 treatment | 239 (15.2) |
Sedation and neuromuscular blockers | 226 (14.4) |
Other | 198 (12.6) |
Prophylaxis | 155 (9.9) |
Electrolytes | 57 (3.6) |
Fluid management | 50 (3.2) |
Adverse drug event avoidance and management | 43 (2.7) |
Drug-drug interactions | 32 (2) |
Respiratory medications | 32 (2) |
Intravenous drips | 29 (1.8) |
Experimental agent trial enrollment | 19 (1.2) |
Interventions per patient receiving therapy, mean (SD) | |
Sedation and neuromuscular blockers | 3.7 (4.7) |
Antimicrobials and COVID-19 treatment | 1.5 (2.2) |
Respiratory medications | 1 (0.9) |
Electrolytes | 0.3 (0.7) |
Abbreviations: DOT, days of therapy.
aData are number (percentage) of total interventions.